The joint venture company will undertake a clinical development and make regulatory submissions globally. After approval, Panacea Biotec and Refana will undertake sales and distribution of the vaccine in their respective territories
from Livemint - Science https://ift.tt/30rCnqR
https://ift.tt/eA8V8J
from Livemint - Science https://ift.tt/30rCnqR
https://ift.tt/eA8V8J
إرسال تعليق